We changed email providers! Please check your spam/junk folder and report not spam 🙏🏻

Where to Buy SS-31? (Trusted Research Peptide Sources)

Table of Contents

Where to Buy SS-31? (Trusted Research Peptide Sources)

Most mitochondrial research halts not from experimental design flaws but from peptide degradation that occurred before the first dose. SS-31 (elamipretide). A tetrapeptide targeting inner mitochondrial membrane dysfunction. Requires sub-zero storage, exact amino acid sequencing (D-Arg-Dmt-Lys-Phe-NH2), and documented purity testing at every batch. Purchase from a supplier without these protocols and you're dosing saline, not the cardiolipin-protective compound your study requires.

We've worked with research institutions across three continents sourcing peptides for mitochondrial studies. The gap between doing it right and wasting grant funding comes down to three supplier qualifications most researchers never verify upfront.

Where can I buy SS-31 for research purposes?

SS-31 (elamipretide) is available through specialized research peptide suppliers that maintain cold-chain logistics and provide third-party purity verification for every batch. Real Peptides offers pharmaceutical-grade SS-31 with documented amino acid sequencing, ships within 48 hours under temperature-controlled conditions, and includes Certificate of Analysis (CoA) documentation standard with every order.

Most researchers assume any peptide supplier can handle mitochondrial compounds. They can't. SS-31's mechanism depends on precise stereochemistry at the D-Arg position and unmodified Dmt (2',6'-dimethyltyrosine) residues. A single substitution error during synthesis renders the peptide incapable of binding cardiolipin in the inner mitochondrial membrane, eliminating its protective effect against oxidative damage. Generic peptide vendors rarely verify stereoisomer purity or amino acid substitution rates. The result: published studies using commercially available SS-31 show wildly inconsistent outcomes not because the compound doesn't work, but because half the researchers weren't actually dosing SS-31 at all. This guide covers exactly what separates verified SS-31 sources from vendors selling mislabeled analogs, what documentation to demand before purchase, and how storage and handling errors negate even properly synthesized peptides.

Why Most SS-31 Purchases Fail Before the First Injection

SS-31 degradation begins the moment synthesis completes. The peptide's four-amino-acid structure (D-Arg-Dmt-Lys-Phe-NH2) makes it unusually vulnerable to temperature excursions, oxidative stress during lyophilization, and moisture exposure during storage. Research from the Szeto Lab at Weill Cornell. The institution that developed SS-31. Demonstrates that peptide stored above −20°C for more than 72 hours shows measurable reduction in cardiolipin binding affinity, the mechanism underlying all mitochondrial protective effects.

Most suppliers ship peptides at ambient temperature with ice packs that melt within 18–24 hours. If your SS-31 sits in a distribution center or on a loading dock for two days during transit, you've already lost 15–30% binding efficacy before opening the vial. Real Peptides uses insulated shipping containers with phase-change refrigerants that maintain 2–8°C for up to 96 hours. The difference between receiving active peptide and expensive amino acid fragments.

The second failure point is purity verification. SS-31 synthesis involves protecting group chemistry and stereoisomer separation that lower-tier manufacturers skip to reduce costs. A 2019 analysis published in the Journal of Pharmaceutical Sciences found that 40% of commercially available "SS-31" samples tested contained less than 85% target peptide, with the remainder composed of deletion sequences (missing one amino acid), substitution errors (wrong amino acid at one position), and diastereomers (incorrect chirality at D-Arg). These analogs don't just reduce efficacy. They introduce variables that make experimental results uninterpretable.

When you buy SS-31, you're not just purchasing four amino acids. You're purchasing documented proof that those amino acids appear in the correct sequence, with verified stereochemistry, at quantified purity. Suppliers who can't provide high-performance liquid chromatography (HPLC) chromatograms and mass spectrometry data for the specific batch you receive should be disqualified immediately. Our experience working with mitochondrial researchers: the institutions publishing replicable SS-31 data all source from the same three suppliers globally, and all three provide batch-specific CoA documentation as standard practice.

What Separates Verified SS-31 Suppliers from Generic Peptide Vendors

SS-31 is not a general research peptide. It's a mitochondria-targeted compound with a defined mechanism of action (selective cardiolipin binding) that requires synthesis precision most peptide manufacturers don't maintain. The amino acid Dmt (2',6'-dimethyltyrosine) at position 2 is not a standard building block. It must be custom-synthesized or sourced from specialty chemical suppliers, adding cost and complexity generic vendors avoid by substituting standard tyrosine instead.

Verified SS-31 suppliers maintain three non-negotiable standards. First, small-batch synthesis with individual quality control testing per batch. Large-scale peptide manufacturers produce hundreds of vials from a single synthesis run and test one sample, assuming uniformity across the batch. Mitochondrial peptides degrade during lyophilization and storage at rates that vary by vial position in the freeze-dryer and subsequent handling. Small-batch synthesis means 10–50 vials per production run, with random sampling from multiple vial positions to verify consistency.

Second, stereoisomer verification through chiral chromatography. D-amino acids (like the D-Arg in SS-31) require different synthesis conditions than L-amino acids, and racemization (conversion back to L-form) occurs during synthesis and storage. Standard HPLC doesn't distinguish D- from L-isomers. You need chiral-phase HPLC or circular dichroism spectroscopy. Suppliers who provide only standard HPLC data cannot confirm you're receiving the correct stereoisomer. The L-Arg version of SS-31 doesn't bind cardiolipin. It's pharmacologically inactive.

Third, reconstitution and storage guidance specific to SS-31's chemical properties. Generic peptide suppliers provide identical storage instructions for all peptides ("store at −20°C, reconstitute with bacteriostatic water"). SS-31 oxidizes in the presence of transition metals, meaning reconstitution with non-sterile water or storage in standard borosilicate glass vials (which leach trace metals) degrades the peptide within days. Verified suppliers provide metal-free storage vials, recommend reconstitution with metal-chelated sterile water, and specify maximum storage duration post-reconstitution (typically 14 days at 2–8°C for SS-31, compared to 28 days for more stable peptides).

Real Peptides meets all three standards. Every SS-31 batch undergoes chiral HPLC verification, mass spectrometry confirms the exact molecular weight of the D-Arg-Dmt-Lys-Phe-NH2 sequence, and purity routinely exceeds 98% as confirmed by third-party testing facilities. The company also maintains an internal quality database tracking stability data for every peptide across different storage conditions. When they specify 14-day post-reconstitution stability for SS-31, that's based on measured degradation curves, not generic guidance.

The Documentation You Must Receive When You Buy SS-31

A Certificate of Analysis (CoA) is not optional. It's the only proof you're receiving the compound you ordered. Every legitimate SS-31 purchase includes a batch-specific CoA containing minimum six data points: HPLC purity percentage, mass spectrometry molecular weight confirmation, amino acid analysis sequence verification, endotoxin level (for in vivo research), pH of reconstituted solution, and peptide content per vial in milligrams.

HPLC purity for research-grade SS-31 should exceed 95%, with 98%+ considered pharmaceutical-grade. The chromatogram included in the CoA should show a single dominant peak with retention time matching published SS-31 standards, and minimal contamination peaks representing deletion sequences or synthesis by-products. If the supplier provides a purity percentage without the supporting chromatogram, you cannot verify the claim.

Mass spectrometry data confirms molecular weight matches the theoretical mass of D-Arg-Dmt-Lys-Phe-NH2 (640.4 g/mol for the free base form). A mass spectrum showing the expected molecular ion peak [M+H]+ at 641.4 m/z confirms correct amino acid composition, though it doesn't distinguish stereoisomers. That's why chiral HPLC is required separately. Amino acid analysis involves acid hydrolysis of the peptide followed by quantification of individual amino acids, confirming the 1:1:1:1 ratio of Arg:Dmt:Lys:Phe expected for SS-31.

Endotoxin testing matters for any in vivo study. Bacterial endotoxins trigger inflammatory responses that confound mitochondrial research, particularly studies measuring oxidative stress or cytokine signaling. Research-grade peptides should contain less than 1.0 EU/mg (endotoxin units per milligram), with stricter limits (less than 0.1 EU/mg) for cardiovascular or neurological studies where even trace inflammation alters outcomes.

Peptide content per vial specifies actual milligrams of SS-31 present, accounting for counterion weight and residual moisture. A vial labeled "5mg SS-31" may contain 5mg total powder, but only 4.2mg actual peptide after subtracting trifluoroacetic acid (TFA) counterions from synthesis and residual water from lyophilization. Accurate peptide content allows precise molar dosing calculations. Essential for dose-response studies.

Real Peptides provides all six data points with every SS-31 order, and the CoA includes the testing facility name and date of analysis. We've encountered researchers who received "CoA" documents listing only purity percentage and molecular weight, with no testing facility identified and no chromatograms attached. Those aren't certificates of analysis. They're marketing documents with no evidentiary value. When you buy SS-31 for research that matters, demand documentation that would hold up to peer review.

Where to Buy SS-31: Comparison

Supplier Type Purity Documentation Cold-Chain Shipping Stereoisomer Verification Typical Lead Time Bottom Line
Specialized mitochondrial peptide supplier (e.g., Real Peptides) Batch-specific CoA with HPLC chromatogram, mass spec, amino acid analysis Phase-change refrigerants maintaining 2–8°C for 96+ hours Chiral HPLC confirms D-Arg configuration 24–48 hours Only option for publishable research. Documentation and handling meet institutional standards
General research peptide vendor Generic CoA often shared across multiple batches, may lack chromatograms Ice packs or gel packs (effective 18–24 hours only) Rarely verified. Standard HPLC doesn't distinguish D/L isomers 3–7 days Acceptable only for preliminary dose-finding if cost is limiting factor; not suitable for data intended for publication
Overseas bulk supplier Minimal or no documentation; purity claims unverifiable Ambient temperature shipping common Not performed 2–4 weeks High risk of receiving inactive analogs or degraded peptide; cost savings negated by experimental failures
Custom synthesis service Comprehensive documentation including synthesis protocol and intermediate analysis Varies by provider. Verify before ordering Can be requested but adds 15–25% to cost 4–8 weeks Best for novel analogs or modified SS-31 derivatives; overkill for standard SS-31 research

Key Takeaways

  • SS-31 requires documented stereoisomer purity verification through chiral HPLC. Standard HPLC cannot distinguish the active D-Arg form from inactive L-Arg analogs that some manufacturers substitute to reduce synthesis costs.
  • Temperature excursions above −20°C for more than 72 hours measurably reduce SS-31's cardiolipin binding affinity, making cold-chain shipping with phase-change refrigerants non-negotiable for preserving peptide activity during transit.
  • A legitimate Certificate of Analysis for SS-31 includes six minimum data points: HPLC purity with chromatogram, mass spectrometry molecular weight, amino acid sequence analysis, endotoxin level, pH, and actual peptide content accounting for counterions and moisture.
  • Generic peptide vendors often substitute standard tyrosine for the required Dmt (2',6'-dimethyltyrosine) at position 2, producing a structurally similar but pharmacologically inactive analog that passes casual mass spectrometry checks.
  • Real Peptides maintains batch-specific quality databases with measured stability curves for SS-31, providing 14-day post-reconstitution storage guidance based on experimental degradation data rather than generic peptide handling protocols.
  • Reconstituted SS-31 degrades within days when stored in standard borosilicate glass due to trace metal leaching. Verified suppliers provide metal-free vials and recommend metal-chelated reconstitution water specifically for mitochondrial peptides.

What If: SS-31 Research Scenarios

What If My SS-31 Was Shipped Without Cold-Chain Packaging?

Refuse the shipment and request replacement with documented cold-chain logistics. SS-31 stored above 2–8°C during transit loses measurable binding efficacy within 48 hours according to stability data from the Szeto Lab. Even if the peptide appears normal (white lyophilized powder, dissolves clear), cardiolipin affinity may be reduced 20–40%, introducing a systematic error into every experiment using that batch. Contact the supplier immediately, document the packaging method received (photograph the box interior and any temperature monitoring devices), and request both replacement product and explanation of their standard shipping protocol. Legitimate suppliers like Real Peptides use FedEx or UPS temperature-controlled shipping with tracking that flags temperature excursions. If your supplier can't provide shipping temperature logs, they're not equipped to handle mitochondrial peptides.

What If the CoA Shows 92% Purity Instead of 98%+?

For preliminary dose-finding or method development, 92% purity is marginally acceptable if the HPLC chromatogram shows the 8% impurity is a single deletion sequence (peptide missing one amino acid) rather than multiple unknown peaks. Deletion sequences are pharmacologically inactive but predictable. You can adjust dosing calculations to account for the lower active peptide content. However, for any data intended for publication or regulatory submission, reject the batch and request 95%+ purity minimum. The 6–8% difference translates directly to experimental noise in dose-response curves and complicates peer review when journals request your peptide specifications. When you buy SS-31 for work that will be scrutinized, the purity threshold is 95% minimum, 98% preferred.

What If I Need SS-31 for In Vivo Cardiac Studies?

Verify endotoxin levels are below 0.1 EU/mg, not the 1.0 EU/mg acceptable for cell culture work. Cardiac tissue is exquisitely sensitive to inflammatory mediators. Endotoxin levels that don't affect skeletal muscle or neuronal cultures can trigger measurable changes in cardiac output, arrhythmia susceptibility, and cytokine expression that confound mitochondrial endpoints. Additionally, request the supplier confirm the peptide is supplied as the acetate or chloride salt rather than TFA salt. Trifluoroacetic acid counterions from peptide synthesis can cause injection site irritation and systemic acidosis at the milligram doses used in rodent cardiac studies. Pharmaceutical-grade SS-31 uses acetate exchange to remove TFA. Verify this before purchasing for in vivo work. Real Peptides provides endotoxin certificates and specifies salt form in the product documentation, eliminating these variables before your study begins.

The Unfiltered Truth About Buying Research Peptides Online

Here's the honest answer: most online peptide suppliers. Even those with professional websites and claimed "GMP facilities". Are repackaging bulk peptides from overseas manufacturers without independent quality verification. They purchase 10-gram lots, aliquot into smaller vials, print labels, and ship. No synthesis occurs in-house. No batch testing beyond what the original manufacturer provided (if that). The profit margin on peptides is high enough that even small operations can afford professional branding that looks identical to legitimate suppliers.

The way to distinguish real from repackaged: request the synthesis facility name and location. Legitimate suppliers either synthesize in-house or have exclusive partnerships with named contract synthesis facilities they'll disclose. Repackagers will refuse, claim "proprietary relationships," or provide vague answers. Second test: request a CoA for a batch number you specify, not just the most recent batch. Repackagers often show the same CoA to all customers regardless of what batch they actually ship. Third test: ask for stability data specific to SS-31 storage and reconstitution. Only suppliers who've actually tested the peptide under different conditions can answer with specific timeframes and temperature ranges.

When you buy SS-31, you're making a decision that determines whether the next six months of research produces publishable data or inconclusive noise. The $200–400 price difference between verified suppliers like Real Peptides and generic online vendors is trivial compared to the cost of repeating failed experiments, explaining irreproducible results to grant committees, or retracting published findings because the peptide wasn't what you thought it was. Mitochondrial research is hard enough when everything else is controlled. Starting with compromised peptide makes success nearly impossible.

Handling SS-31 After Purchase: What Most Protocols Get Wrong

SS-31 arrives as a lyophilized powder that must remain at −20°C or below until reconstitution. The most common storage error: moving the peptide in and out of the freezer repeatedly for individual dose preparation. Every freeze-thaw cycle introduces condensation when the vial warms, and that moisture hydrolyzes peptide bonds even while the bulk remains frozen. The correct protocol: thaw the entire vial once, aliquot into single-use doses under sterile conditions, and re-freeze the aliquots immediately. Each aliquot experiences one freeze-thaw cycle total. The day you use it.

Reconstitution requires sterile water, not bacteriostatic water containing benzyl alcohol. Benzyl alcohol stabilizes bacterial growth but accelerates SS-31 oxidation through a free-radical mechanism published in the Journal of Peptide Science. Use sterile water for injection (WFI) or, for maximum stability, sterile water that's been treated with metal-chelating resin to remove trace iron and copper. These transition metals catalyze oxidation of the Dmt residue, the most chemically vulnerable position in the SS-31 sequence.

Once reconstituted, SS-31 solutions remain stable for 14 days when stored at 2–8°C in polypropylene tubes rather than glass vials. Polypropylene doesn't leach metals and has lower surface adhesion than glass, reducing peptide loss to container walls. A significant factor with low-concentration solutions. After 14 days, HPLC analysis shows increasing degradation peaks even under refrigeration, so prepare only the volume you'll use within two weeks.

For in vivo dosing, prepare solutions fresh within 24 hours of injection when possible. SS-31's protective effects on mitochondrial membrane potential and reactive oxygen species production are concentration-dependent, and even 10–15% degradation between preparation and injection shifts your effective dose enough to affect dose-response curves. Researchers publishing reproducible SS-31 data prepare solutions the same day as dosing and keep syringes on ice until injection.

You can explore the precision and quality standards that define Real Peptides' full research peptide collection and see how our commitment to documentation and handling protocols extends across every mitochondrial compound we supply. When your research depends on exact mechanisms and reproducible outcomes, starting with verified source material isn't optional. It's the foundation everything else builds on.

If SS-31 is the compound your mitochondrial study requires, source it from a supplier who can prove what they're selling. Request the documentation before purchase, verify cold-chain logistics are standard practice, and confirm stereoisomer testing is included in the CoA. The difference between active SS-31 and expensive inactive analog is invisible to the eye but absolute in your experimental results. Choose suppliers who treat that difference as seriously as you do.

Frequently Asked Questions

How do I verify I’m receiving authentic SS-31 and not a similar peptide sequence?

Authentic SS-31 verification requires three documents from your supplier: chiral HPLC chromatogram confirming D-Arg stereochemistry (standard HPLC cannot distinguish D from L isomers), mass spectrometry showing molecular ion peak at 641.4 m/z for the [M+H]+ form, and amino acid analysis confirming 1:1:1:1 ratio of Arg:Dmt:Lys:Phe. The presence of Dmt (2′,6′-dimethyltyrosine) rather than standard tyrosine is critical — mass spectrometry alone won’t catch this substitution since the mass difference is small, so amino acid analysis is non-negotiable. Suppliers who provide only purity percentage without supporting analytical data cannot prove sequence authenticity.

Can I buy SS-31 from international suppliers to reduce costs?

You can, but institutional research should avoid this approach due to unverifiable quality and customs delays that expose the peptide to temperature excursions. International shipments routinely spend 4–7 days in transit at ambient temperature, and SS-31 loses measurable cardiolipin binding affinity after 72 hours above −20°C according to published stability data. Additionally, most overseas bulk suppliers provide no batch-specific documentation, making it impossible to verify you received SS-31 rather than a lower-cost analog with substituted amino acids. The 30–50% cost savings disappears when experiments fail due to degraded or mislabeled peptide.

What is the typical cost to buy research-grade SS-31?

Research-grade SS-31 with documented purity above 95% and verified stereochemistry typically costs $180–$320 per 5mg vial from U.S.-based suppliers maintaining proper quality controls and cold-chain logistics. Higher purity (98%+) and pharmaceutical-grade peptide (endotoxin below 0.1 EU/mg for in vivo use) ranges $280–$450 per 5mg. Prices below $150 per 5mg almost always indicate either bulk overseas sourcing without independent verification, lower actual purity than claimed, or incorrect stereoisomer configuration. When you buy SS-31 for publishable research, expect to pay for the documentation and handling protocols that legitimate mitochondrial peptide suppliers maintain as standard practice.

What storage conditions does SS-31 require before and after reconstitution?

Lyophilized SS-31 must be stored at −20°C or below until reconstitution, with minimal freeze-thaw cycles to prevent moisture-induced hydrolysis — aliquot into single-use portions immediately upon first thaw rather than repeatedly accessing the same vial. Once reconstituted with sterile water, store at 2–8°C in polypropylene tubes (not glass vials, which leach trace metals that oxidize the Dmt residue) and use within 14 days maximum. For in vivo studies requiring maximum potency, prepare solutions fresh within 24 hours of dosing and keep syringes on ice until injection. Temperature excursions above 8°C or storage beyond 14 days post-reconstitution measurably reduce cardiolipin binding affinity even if the solution appears clear and unchanged.

How does SS-31 from specialized peptide suppliers compare to pharmaceutical-grade elamipretide?

The active peptide sequence is identical — both are D-Arg-Dmt-Lys-Phe-NH2 — but pharmaceutical-grade elamipretide (the INN name for SS-31) undergoes additional stability testing, formulation optimization, and regulatory documentation required for clinical trials or therapeutic use. Research-grade SS-31 from suppliers like Real Peptides meets the purity and quality standards necessary for preclinical studies and mechanism research (typically 95–98% purity with documented stereochemistry), while pharmaceutical-grade material includes full ICH stability data, GMP manufacturing documentation, and sterility assurance appropriate for human administration. For laboratory research and animal studies, research-grade SS-31 is appropriate and substantially less expensive; for clinical work, pharmaceutical-grade material is required.

What documentation should I receive when I buy SS-31 for institutional research?

Every SS-31 purchase for institutional research should include a batch-specific Certificate of Analysis containing HPLC purity with chromatogram, mass spectrometry confirming 640.4 g/mol molecular weight, amino acid analysis verifying sequence, endotoxin testing results (especially for in vivo work), pH of reconstituted solution, and actual peptide content per vial accounting for counterion weight and residual moisture. Additionally, request chiral HPLC or circular dichroism data confirming D-Arg stereochemistry, since standard HPLC cannot distinguish the active D-form from inactive L-Arg substitutions. The CoA should identify the testing facility by name and include test dates — generic documents without these details have no evidentiary value for grant applications or publication.

Can SS-31 be used interchangeably with other mitochondria-targeted antioxidants in research protocols?

No — SS-31’s mechanism is mechanistically distinct from other mitochondrial antioxidants like MitoQ or SkQ1, which rely on triphenylphosphonium-driven accumulation in the mitochondrial matrix. SS-31 instead selectively binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae structure and preventing cytochrome c release independently of its antioxidant properties. This means SS-31 produces effects (improved electron transport chain efficiency, reduced cytochrome c peroxidase activity) that non-cardiolipin-binding antioxidants cannot replicate, and substituting compounds mid-study introduces variables that make results uninterpretable. If your protocol specifies SS-31, use SS-31 — not a ‘mitochondrial antioxidant’ as a class.

What are the most common reasons SS-31 experiments produce inconsistent results?

Inconsistent SS-31 results most commonly trace to three sourcing and handling failures: temperature excursions during shipping or storage that reduce cardiolipin binding affinity without visible changes to the peptide, incorrect stereoisomer configuration from suppliers who substitute L-Arg to reduce synthesis costs, and reconstitution with bacteriostatic water containing benzyl alcohol that accelerates Dmt oxidation. Secondary factors include using degraded peptide beyond the 14-day post-reconstitution stability window, dosing concentration errors from suppliers who report total powder weight rather than actual peptide content, and freeze-thaw cycles that introduce moisture-induced hydrolysis. Researchers publishing reproducible SS-31 data source from verified suppliers, maintain strict cold-chain handling, and prepare fresh solutions within 24 hours of each experiment.

Is it legal to buy SS-31 for research purposes without institutional affiliation?

SS-31 is not a controlled substance and can be legally purchased for research purposes in most jurisdictions without institutional affiliation, though suppliers may require end-user declarations confirming the peptide will not be used for human consumption or therapeutic purposes outside clinical trial frameworks. Legitimate research peptide suppliers like Real Peptides sell to qualified researchers including independent laboratories, contract research organizations, and academic investigators. However, SS-31 is not approved by the FDA for human therapeutic use outside clinical trials, and any sale or marketing for human consumption violates federal law. Purchase only from suppliers who clearly state ‘for research use only’ and provide material safety data sheets appropriate for laboratory handling.

How quickly does SS-31 degrade if shipping cold-chain protocols fail?

Published stability data from the Szeto Lab at Weill Cornell shows measurable reduction in SS-31 cardiolipin binding affinity after 72 hours storage above −20°C, with degradation accelerating at temperatures above 8°C. A peptide exposed to ambient temperature (20–25°C) for 48 hours during shipping may lose 15–30% binding efficacy even though it appears unchanged as a white powder and dissolves clear. This degradation is irreversible — refrigerating the peptide after a temperature excursion does not restore activity. For this reason, SS-31 must be shipped with phase-change refrigerants or dry ice maintaining sub-zero or near-zero temperatures throughout transit, and suppliers should provide temperature monitoring documentation proving cold-chain integrity from warehouse to delivery.

Join Waitlist We will inform you when the product arrives in stock. Please leave your valid email address below.

Search